Ligand validation:2VJO

EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2VJO_EPE_A_1431	52%	31%	0.159	0.915	0.83	1.88	1	4	0	0	100%	0.8
2VJN_EPE_B_1429	83%	56%	0.097	0.956	0.69	0.98	1	2	0	0	100%	1
2VJM_EPE_B_1430	64%	46%	0.131	0.931	0.82	1.27	1	2	1	0	100%	0.8
2VJQ_EPE_D_1429	44%	49%	0.165	0.892	0.87	1.09	1	2	0	0	100%	0.8
1XX1_EPE_C_2003	100%	37%	0.024	0.996	0.73	1.72	1	4	1	0	100%	1
3EC7_EPE_E_401	100%	10%	0.031	0.993	1.1	3.18	1	11	1	0	100%	1
2BDU_EPE_B_402	100%	29%	0.033	0.993	0.87	1.95	1	5	0	0	100%	1
8VCQ_EPE_F_201	100%	60%	0.044	0.984	0.85	0.68	1	-	1	0	100%	1
8XBN_EPE_A_301	99%	69%	0.05	0.985	0.39	0.79	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.